Comera Life Sciences Holdings Inc 's

• CMRA's Stock Performance relative to its Competitors

Metavia Inc Share Performance -76.66% One Year

Metavia Inc Profile The company is a clinical-stage biotechnology firm focused on developing drugs for cardiometabolic diseases, including MASH and obesity. More about Metavia Inc 's Market Share

Innoviva Inc Share Performance +2.44% 30 Days

Innoviva Inc Profile Innoviva Inc's business model revolves around the development and commercialization of pharmaceutical products. The company primarily focuses on creating strategic collaborations and partnerships with biopharmaceutical companies to advance innovative therapies. Innoviva generates revenue through royalty payments received based on the sales of its partnered products. More about Innoviva Inc 's Market Share

Atea Pharmaceuticals Inc Share Performance +27.28% This Quarter

Atea Pharmaceuticals Inc Profile Atea Pharmaceuticals Inc. is a biopharmaceutical company that focuses on developing antiviral therapeutics to combat infectious diseases. Their business model revolves around identifying and advancing novel drug candidates that target specific viral mechanisms and inhibit their replication. This includes conducting preclinical and clinical trials, engaging in strategic partnerships, and ultimately bringing effective antiviral treatments to market. More about Atea Pharmaceuticals Inc 's Market Share

Myovant Sciences Ltd Share Performance +0.71% This Quarter

Myovant Sciences Ltd Profile Myovant Sciences Ltd operates under a biopharmaceutical business model primarily focused on the development and commercialization of therapies for women's health and prostate cancer. The company aims to leverage its expertise in clinical research, regulatory affairs, and manufacturing to bring innovative treatments to market and improve patients' lives. Myovant Sciences employs a combination of in-house research and development along with collaboration with strategic partners to advance its pipeline of product candidates. More about Myovant Sciences Ltd 's Market Share

Medicinova Inc Share Performance +8.35% This Year

Medicinova Inc Profile Medicinova Inc operates under a biopharmaceutical business model, primarily focused on the development and commercialization of innovative therapeutics. They strive to identify promising drug candidates with the potential to address unmet medical needs and advance them through clinical trials. By leveraging their research capabilities, strategic partnerships, and licensing opportunities, Medicinova Inc aims to bring these novel treatments to market and improve patient outcomes. More about Medicinova Inc 's Market Share

Sources: Comera Life Sciences Holdings Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Wednesday, September 2, 2026 5:04 PM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Comera Life Sciences Holdings Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.